Home > Income Statement > AJANTA PHARMA

AJANTA PHARMA
Revenue

    Back to Income Statement
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹4,209 Cr₹3,743 Cr₹3,341 Cr₹2,890 Cr₹2,588 Cr

What is the latest Revenue of AJANTA PHARMA ?

The latest Revenue ratio of AJANTA PHARMA is ₹4,209 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹4,209 Cr
Mar2023₹3,743 Cr
Mar2022₹3,341 Cr
Mar2021₹2,890 Cr
Mar2020₹2,588 Cr

How is Revenue of AJANTA PHARMA Trending?

Years Revenue % Change
Mar2024 ₹4,209 Cr
12.45
Mar2023 ₹3,743 Cr
12.02
Mar2022 ₹3,341 Cr
15.62
Mar2021 ₹2,890 Cr
11.66
Mar2020 ₹2,588 Cr -

Compare Revenue of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹35,053.2 Cr -1.5% -1.2% 50.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹435,179.0 Cr 0.4% 0.8% 45.4% Stock Analytics
DIVIS LABORATORIES ₹155,995.0 Cr -1.4% 1.2% 62% Stock Analytics
CIPLA ₹116,890.0 Cr -1.5% -5.1% 20.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,993.0 Cr -0.7% -1.3% 13.8% Stock Analytics
ZYDUS LIFESCIENCES ₹98,444.9 Cr -0.5% 3% 54.1% Stock Analytics


AJANTA PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

-1.5%

-1.2%

50.4%

SENSEX

0.5%

3.3%

17.6%


You may also like the below Video Courses